1. Mitochondrial involvement in a Bosch-Boonstra-Schaaf optic atrophy syndrome patient with a novel de novo NR2F1 gene mutation.
- Author
-
Martín-Hernández E, Rodríguez-García ME, Chen CA, Cotrina-Vinagre FJ, Carnicero-Rodríguez P, Bellusci M, Schaaf CP, and Martínez-Azorín F
- Subjects
- Alleles, Amino Acid Sequence, Amino Acid Substitution, Biomarkers, Cell Respiration, Electroencephalography, Female, Genetic Association Studies, Genotype, Humans, Magnetic Resonance Imaging, Mitochondria metabolism, Pedigree, Phenotype, Syndrome, Exome Sequencing, COUP Transcription Factor I genetics, Mitochondria genetics, Mutation, Optic Atrophy diagnosis, Optic Atrophy genetics
- Abstract
We report the clinical and biochemical findings from a patient who presented with Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS), an autosomal-dominant disorder characterized by optic atrophy, developmental delay and intellectual disability. In addition, the patient also displays hypotonia, stroke-like episodes, and complex IV deficiency of the mitochondrial respiratory chain. Whole-exome sequencing (WES) uncovered a novel heterozygous mutation in the NR2F1 gene (NM_005654:c.286A>G:p.Lys96Glu) that encodes for the COUP transcription factor 1 protein (COUP-TF1). Loss-of-function mutations in this protein have been associated with BBSOAS, and a luciferase reporter assay showed that this variant, in the zinc-finger DNA-binding domain (DBD) of COUP-TF1 protein, impairs its transcriptional activity. The additional features of this patient are more related with mitochondrial diseases that with BBSOAS, indicating a mitochondrial involvement. Finally, our data expand both the genetic and phenotypic spectrum associated with NR2F1 gene mutations.
- Published
- 2018
- Full Text
- View/download PDF